Thetis Pharmaceuticals is a biopharmaceutical company developing novel "immuno-resolving" therapies to treat Inflammatory Bowel Disease (IBD). Thetis has a differentiated approach based on resolving inflammation and promoting tissue regeneration without compromising the body's ability to fight infection. The company's drugs agents are based on naturally occurring lipids that play a critical role in regulating the body's normal inflammatory response. \\Through its proprietary HEALER™ technology platform, Thetis overcome the stability, manufacturing, formulation and patentability hurdles that have limited the development of these lipids as pharmaceutical agents. This technology unlocks the potent pharmacology of these lipids as patented new molecular entities. Thetis agents are targeted as safe, oral therapies prior to escalation to immunosuppressive therapies including biologics.